Bone Biologics Corporatio... (BBLGW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
59.20
-8.80 (-12.94%)
At close: Jan 14, 2025, 9:00 PM
67.35
13.77%
Pre-market Jan 15, 2025, 11:09 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 877.78K | n/a | n/a | 3.00K | 3.00K | 3.00K | n/a |
Gross Profit | n/a | n/a | n/a | n/a | -50 | -96 | -96 | -700 | -4.45K | -877.78K | n/a | n/a | -3.00K | -3.00K | -3.00K | n/a |
Operating Income | -9.43M | -3.67M | -1.10M | -825.01K | -2.45M | -2.79M | -2.63M | -17.85M | -12.00M | -3.01M | -671.99K | -435.66 | -3.00K | -3.00K | -3.00K | -13.34K |
Interest Income | 1.87K | 731.71 | 805.11 | 998.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -8.95M | -1.48M | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.87M | -4.42M | -1.08M | -714.76 | n/a | n/a | n/a | -13.34K |
Net Income | -8.95M | 695.93K | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.88M | -4.42M | -1.08M | -715.57 | n/a | n/a | n/a | -13.34K |
Selling & General & Admin | 2.52M | 2.09M | 1.02M | 484.34K | 1.35M | 2.69M | 3.82M | 6.25M | 8.33M | 1.51M | 483.75K | 180.09 | n/a | n/a | n/a | n/a |
Research & Development | 6.91M | 1.58M | 82.04K | 340.67K | 1.10M | 104.49K | -1.19M | 11.60M | 3.67M | 623.52K | 188.24K | 255.57 | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 104.49K | 2.63M | n/a | n/a | -9.62K | n/a | n/a | n/a | n/a | n/a | -13.34K |
Operating Expenses | 9.43M | 3.67M | 1.10M | 825.01K | 2.45M | 2.79M | 2.63M | 17.85M | 12.00M | 3.01M | 671.99K | 435.66 | n/a | n/a | n/a | -13.34K |
Interest Expense | n/a | n/a | 805.11K | 998.08K | 975.77K | 1.23M | 4.42M | 3.17M | 1.87M | 1.40M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.43M | 3.67M | 1.10M | 825.01K | 2.45M | 2.79M | 2.63M | 17.85M | 12.00M | 3.01M | 671.99K | 435.66 | 3.00K | 3.00K | 3.00K | -13.34K |
Income Tax | n/a | -2.18M | 1.60K | 1.60K | 1.60K | 1.73K | 1.60K | 2.24K | 8.84K | 1.60K | 800.00 | 0.80 | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 263.14K | 47.00K | 43.00K | 51.00K | 51.00K | n/a | n/a | n/a | n/a | n/a | n/a | 14.00 | 5.00M | 5.00M | 5.00M | 5.00M |
Shares Outstanding (Diluted) | 263.14K | 47.66K | 43.13K | 51.14K | 51.14K | n/a | n/a | n/a | n/a | n/a | n/a | 14.57 | 5.00M | 5.00M | 5.00M | 5.00M |
EPS (Basic) | -34.01 | -31.15 | -37.35 | -35.68 | -66.97 | n/a | n/a | n/a | n/a | n/a | n/a | -49.11 | n/a | n/a | n/a | -0.00 |
EPS (Diluted) | -34.01 | -31.15 | -37.35 | -35.68 | -66.97 | n/a | n/a | n/a | n/a | n/a | n/a | -49.11 | n/a | n/a | n/a | -0.00 |
EBITDA | 479.57K | n/a | n/a | -825.01K | -2.45M | -2.79M | -2.63M | -20.41M | -11.99M | -3.02M | n/a | -5.23K | -4.52K | -3.00K | -3.00K | -13.34K |
Depreciation & Amortization | 9.43M | 3.67M | 1.10M | 50.00 | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 280.00 | 671.99K | 435.66 | n/a | n/a | n/a | n/a |